Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, hematological disorders and exposure to radiation. Our vision is to leverage our advanced technology and our position as a global leader in cell therapy to develop, manufacture and market highly effective cell products that will heal patients around the world.